Interestingly, SMC1A is overexpressed in untreated CRC samples (data not shown) and following bevacizumab treatment there were sixteen dysregulated genes in common with our bevacizumab-treated tumors (Supplementary Table S6). This evidence concerns the gene SMC1A and colorectal carcinoma.